+ +

•  

   

     The image is immunohistochemistry of paraffin-embedded Human esophagus cancer tissue using P05466(TEX37 Antibody) at dilution 1/40. (Original magnification: ×200)    

  
  

The TEX37 antibody targets the protein encoded by the TEX37 gene, a member of the cancer/testis (CT) antigen family. CT antigens are characterized by their restricted expression in germline cells (primarily testes) and aberrant reactivation in various cancers. TEX37. initially identified through genomic and transcriptomic analyses, exhibits testis-specific expression under normal physiological conditions. However, its ectopic expression has been detected in malignancies such as melanoma, lung, and breast cancers, suggesting potential roles in oncogenesis or cancer progression.

TEX37 antibodies are primarily used as research tools to investigate the protein's expression patterns, subcellular localization, and functional mechanisms. Their applications include immunohistochemistry (IHC), Western blotting (WB), and immunofluorescence (IF) to validate TEX37 overexpression in tumor tissues compared to normal counterparts. Such studies aim to explore its utility as a diagnostic biomarker or immunotherapeutic target, leveraging the immune system's ability to recognize CT antigens.

Current research focuses on understanding TEX37's biological significance, including its involvement in cell proliferation, apoptosis, or immune evasion. Challenges remain in elucidating its precise molecular pathways and clinical relevance across cancer types. Despite limited data, TEX37 antibodies hold promise for advancing cancer biology and therapeutic strategies, particularly in personalized oncology. Further validation is required to establish their diagnostic or therapeutic viability.